Claus-Michael Lehr - Catalent
Catalent was named last week as the supplier of delayed-release technology for Supernus’ epilepsy treatment Trokendi Applied Drug Delivery Institute, and this week it has announced Professor Claus-Michael Lehr has been appointed to the Catalent Applied Drug Delivery Institute’ Board.
Currently Head of the Department of Biopharmaceutics and Pharmaceutical Technology, Saarland University, Germany, Lehr has over 15 years of experience in research in ways to overcome biological barriers to effective drug delivery.
“Professor Lehr’s research experience in drug delivery, coupled with his outstanding connections within our industry, will be great assets to the Institute,” said Terry Robinson, Executive Director of the Catalent Applied Drug Delivery Institute.